Published in Genes Dev on April 01, 1996
Targeted disruption of the cyclin-dependent kinase 5 gene results in abnormal corticogenesis, neuronal pathology and perinatal death. Proc Natl Acad Sci U S A (1996) 4.16
Hgc1, a novel hypha-specific G1 cyclin-related protein regulates Candida albicans hyphal morphogenesis. EMBO J (2004) 2.72
Critical role of CDK5 and Polo-like kinase 2 in homeostatic synaptic plasticity during elevated activity. Neuron (2008) 2.29
Cocaine-induced proliferation of dendritic spines in nucleus accumbens is dependent on the activity of cyclin-dependent kinase-5. Neuroscience (2003) 2.19
The in vivo roles of STEF/Tiam1, Rac1 and JNK in cortical neuronal migration. EMBO J (2003) 1.92
Cdk5 regulates accurate maturation of newborn granule cells in the adult hippocampus. PLoS Biol (2008) 1.92
Molecular mechanisms of neurodegeneration in Alzheimer's disease. Hum Mol Genet (2010) 1.90
Cyclin E constrains Cdk5 activity to regulate synaptic plasticity and memory formation. Dev Cell (2011) 1.89
Cyclin-dependent kinase 5 is a mediator of dopaminergic neuron loss in a mouse model of Parkinson's disease. Proc Natl Acad Sci U S A (2003) 1.87
Regulation of NMDA receptors by cyclin-dependent kinase-5. Proc Natl Acad Sci U S A (2001) 1.73
The regulation of SIRT2 function by cyclin-dependent kinases affects cell motility. J Cell Biol (2008) 1.63
Control of axon elongation via an SDF-1alpha/Rho/mDia pathway in cultured cerebellar granule neurons. J Cell Biol (2003) 1.58
Inhibiting the cyclin-dependent kinase CDK5 blocks pancreatic cancer formation and progression through the suppression of Ras-Ral signaling. Cancer Res (2010) 1.54
An unusual member of the Cdk family: Cdk5. Cell Mol Neurobiol (2008) 1.36
Glutamate slows axonal transport of neurofilaments in transfected neurons. J Cell Biol (2000) 1.33
Distinct priming kinases contribute to differential regulation of collapsin response mediator proteins by glycogen synthase kinase-3 in vivo. J Biol Chem (2006) 1.33
Roscovitine: a novel regulator of P/Q-type calcium channels and transmitter release in central neurons. J Physiol (2002) 1.32
Tissue inhibitor of metalloproteinase-2 promotes neuronal differentiation by acting as an anti-mitogenic signal. J Neurosci (2005) 1.25
Lis1 and Ndel1 influence the timing of nuclear envelope breakdown in neural stem cells. J Cell Biol (2008) 1.25
Neurofilament heavy chain side arm phosphorylation regulates axonal transport of neurofilaments. J Cell Biol (2003) 1.24
Cdk5 regulates the organization of Nestin and its association with p35. Mol Cell Biol (2003) 1.24
Cyclin G2 is a centrosome-associated nucleocytoplasmic shuttling protein that influences microtubule stability and induces a p53-dependent cell cycle arrest. Exp Cell Res (2006) 1.22
Cdk5 suppresses the neuronal cell cycle by disrupting the E2F1-DP1 complex. J Neurosci (2010) 1.21
Evidence for the role of MAP1B in axon formation. Mol Biol Cell (2001) 1.20
RNAs induced by Epstein-Barr virus nuclear antigen 2 in lymphoblastoid cell lines. Proc Natl Acad Sci U S A (2006) 1.17
Cdk5 Modulation of mitogen-activated protein kinase signaling regulates neuronal survival. Mol Biol Cell (2006) 1.16
Achaete-scute homologue-1 (ASH1) stimulates migration of lung cancer cells through Cdk5/p35 pathway. Mol Biol Cell (2012) 1.12
A 24-residue peptide (p5), derived from p35, the Cdk5 neuronal activator, specifically inhibits Cdk5-p25 hyperactivity and tau hyperphosphorylation. J Biol Chem (2010) 1.11
Phosphorylation of paxillin by p38MAPK is involved in the neurite extension of PC-12 cells. J Cell Biol (2004) 1.11
CDK5 is essential for TGF-β1-induced epithelial-mesenchymal transition and breast cancer progression. Sci Rep (2013) 1.11
A Cdk5-dependent switch regulates Lis1/Ndel1/dynein-driven organelle transport in adult axons. J Neurosci (2011) 1.10
Deregulated Cdk5 activity is involved in inducing Alzheimer's disease. Arch Med Res (2012) 1.08
Novel genetic tools reveal Cdk5's major role in Golgi fragmentation in Alzheimer's disease. Mol Biol Cell (2008) 1.07
Mammalian Cdk5 is a functional homologue of the budding yeast Pho85 cyclin-dependent protein kinase. Proc Natl Acad Sci U S A (1999) 1.07
Regulation of cyclin-dependent kinase 5 catalytic activity by phosphorylation. Proc Natl Acad Sci U S A (1999) 1.07
Cdk5 nuclear localization is p27-dependent in nerve cells: implications for cell cycle suppression and caspase-3 activation. J Biol Chem (2010) 1.06
In vivo analysis of the domains of yeast Rvs167p suggests Rvs167p function is mediated through multiple protein interactions. Genetics (1999) 1.06
Ethanol inhibition of aspartyl-asparaginyl-beta-hydroxylase in fetal alcohol spectrum disorder: potential link to the impairments in central nervous system neuronal migration. Alcohol (2009) 1.04
A truncated peptide from p35, a Cdk5 activator, prevents Alzheimer's disease phenotypes in model mice. FASEB J (2012) 1.03
A cyclin-dependent kinase family member (PHOA) is required to link developmental fate to environmental conditions in Aspergillus nidulans. EMBO J (1998) 1.02
Drebrin contains a cryptic F-actin-bundling activity regulated by Cdk5 phosphorylation. J Cell Biol (2013) 0.99
Targeting cyclin-dependent kinases in human cancers: from small molecules to Peptide inhibitors. Cancers (Basel) (2015) 0.99
Nerve Growth factor regulation of cyclin D1 in PC12 cells through a p21RAS extracellular signal-regulated kinase pathway requires cooperative interactions between Sp1 and nuclear factor-kappaB. Mol Biol Cell (2008) 0.98
Exercise decreases myelin-associated glycoprotein expression in the spinal cord and positively modulates neuronal growth. Glia (2007) 0.97
The Cdk5-p35 kinase associates with the Golgi apparatus and regulates membrane traffic. EMBO Rep (2001) 0.96
Modulation of aberrant CDK5 signaling rescues impaired neurogenesis in models of Alzheimer's disease. Cell Death Dis (2011) 0.95
Rational Polypharmacology: Systematically Identifying and Engaging Multiple Drug Targets To Promote Axon Growth. ACS Chem Biol (2015) 0.93
Salicylic acid-derived poly(anhydride-ester) electrospun fibers designed for regenerating the peripheral nervous system. J Biomed Mater Res A (2011) 0.93
Cadherins and synaptic plasticity: activity-dependent cyclin-dependent kinase 5 regulation of synaptic beta-catenin-cadherin interactions. Philos Trans R Soc Lond B Biol Sci (2003) 0.93
Cell cycle-dependent ubiquitylation and destruction of NDE1 by CDK5-FBW7 regulates ciliary length. EMBO J (2015) 0.92
Regulation of Cdh1-APC function in axon growth by Cdh1 phosphorylation. J Neurosci (2009) 0.92
CDK-5 regulates the abundance of GLR-1 glutamate receptors in the ventral cord of Caenorhabditis elegans. Mol Biol Cell (2007) 0.92
Effects of substrate stiffness and cell density on primary hippocampal cultures. J Biosci Bioeng (2010) 0.91
Cyclin-dependent kinase 5 activates guanine nucleotide exchange factor GIV/Girdin to orchestrate migration-proliferation dichotomy. Proc Natl Acad Sci U S A (2015) 0.89
Absence of the Cdk5 activator p35 causes adult-onset neurodegeneration in the central brain of Drosophila. Dis Model Mech (2011) 0.89
Attention-deficit/hyperactivity phenotype in mice lacking the cyclin-dependent kinase 5 cofactor p35. Biol Psychiatry (2010) 0.88
Ca2+/Calmodulin-dependent protein kinase kinase beta is regulated by multisite phosphorylation. J Biol Chem (2011) 0.88
Ubiquitin C-terminal hydrolase L1 (UCH-L1) acts as a novel potentiator of cyclin-dependent kinases to enhance cell proliferation independently of its hydrolase activity. J Biol Chem (2013) 0.87
Rodent models of neuroinflammation for Alzheimer's disease. J Neuroinflammation (2015) 0.87
Molecular characterization of Pegarn: a Drosophila homolog of UNC-51 kinase. Mol Biol Rep (2008) 0.87
Drosophila lacking the Cdk5 activator, p35, display defective axon guidance, age-dependent behavioral deficits and reduced lifespan. Mech Dev (2007) 0.85
Neuronal Per Arnt Sim (PAS) domain protein 4 (NPAS4) regulates neurite outgrowth and phosphorylation of synapsin I. J Biol Chem (2012) 0.84
Role of cyclins in neuronal differentiation of immortalized hippocampal cells. Mol Cell Biol (1997) 0.84
Phosphorylation of AATYK1 by Cdk5 suppresses its tyrosine phosphorylation. PLoS One (2010) 0.84
Deciphering the molecular profile of plaques, memory decline and neuron loss in two mouse models for Alzheimer's disease by deep sequencing. Front Aging Neurosci (2014) 0.83
Suppressor of cytokine signalling-6 promotes neurite outgrowth via JAK2/STAT5-mediated signalling pathway, involving negative feedback inhibition. PLoS One (2011) 0.83
Small-molecule screening of PC3 prostate cancer cells identifies tilorone dihydrochloride to selectively inhibit cell growth based on cyclin-dependent kinase 5 expression. Oncol Rep (2014) 0.83
Increased synaptophysin is involved in inflammation-induced heat hyperalgesia mediated by cyclin-dependent kinase 5 in rats. PLoS One (2012) 0.83
Cyclin-dependent kinase 5, a node protein in diminished tauopathy: a systems biology approach. Front Aging Neurosci (2014) 0.83
Stress-Induced CDK5 Activation Disrupts Axonal Transport via Lis1/Ndel1/Dynein. Cell Rep (2015) 0.82
Review: tauopathy in the retina and optic nerve: does it shadow pathological changes in the brain? Mol Vis (2012) 0.82
Actin interaction and regulation of cyclin-dependent kinase 5/p35 complex activity. J Neurochem (2011) 0.81
Cyclin e1 regulates Kv2.1 channel phosphorylation and localization in neuronal ischemia. J Neurosci (2014) 0.81
Cloning and characterization of zebrafish (Danio rerio) cyclin-dependent kinase 5. Neurosci Lett (2006) 0.81
Cdk5-mediated phosphorylation of delta-catenin regulates its localization and GluR2-mediated synaptic activity. J Neurosci (2010) 0.80
The involvement of Cdk5 activator p35 in social isolation-triggered onset of early Alzheimer's disease-related cognitive deficit in the transgenic mice. Neuropsychopharmacology (2011) 0.80
Cdk5: mediator of neuronal development, death and the response to DNA damage. Mech Ageing Dev (2011) 0.80
Cdk5 inhibitory peptide (CIP) inhibits Cdk5/p25 activity induced by high glucose in pancreatic beta cells and recovers insulin secretion from p25 damage. PLoS One (2013) 0.79
Alzheimer's Disease: Mechanism and Approach to Cell Therapy. Int J Mol Sci (2015) 0.79
Cyclin-dependent kinase 5 is required for normal cerebellar development. Mol Cell Neurosci (2012) 0.79
Mechanisms of HIV-1 Tat neurotoxicity via CDK5 translocation and hyper-activation: role in HIV-associated neurocognitive disorders. Curr HIV Res (2015) 0.79
Specific inhibition of cyclin-dependent kinase 5 activity induces motor neuron development in vivo. Biochem Biophys Res Commun (2009) 0.79
Dominant negative effect of polyglutamine expansion perturbs normal function of ataxin-3 in neuronal cells. Hum Mol Genet (2014) 0.78
SILAC-based proteomic analysis to investigate the impact of amyloid precursor protein expression in neuronal-like B103 cells. Electrophoresis (2012) 0.78
Role of a cdk5-associated protein, p35, in herpes simplex virus type 1 replication in vivo. J Neurovirol (2010) 0.78
Cdk5-Foxo3 axis: initially neuroprotective, eventually neurodegenerative in Alzheimer's disease models. J Cell Sci (2016) 0.78
PHF-like tau phosphorylation in mammalian hibernation is not associated with p25-formation. J Neural Transm (Vienna) (2009) 0.77
Prolyl Isomerase Pin1 Regulates Axon Guidance by Stabilizing CRMP2A Selectively in Distal Axons. Cell Rep (2015) 0.77
A Unified Hypothesis of Early- and Late-Onset Alzheimer's Disease Pathogenesis. J Alzheimers Dis (2015) 0.77
Cyclic AMP and Polyamines Overcome Inhibition by Myelin-Associated Glycoprotein through eIF5A-Mediated Increases in p35 Expression and Activation of Cdk5. J Neurosci (2016) 0.76
Computational study of the inhibitory mechanism of the kinase CDK5 hyperactivity by peptide p5 and derivation of a pharmacophore. J Comput Aided Mol Des (2016) 0.76
p35 regulates the CRM1-dependent nucleocytoplasmic shuttling of nuclear hormone receptor coregulator-interacting factor 1 (NIF-1). PLoS One (2014) 0.76
Revisiting CDK Inhibitors for Treatment of Glioblastoma Multiforme. Drugs R D (2017) 0.75
Regulation of neuronal cav3.1 channels by cyclin-dependent kinase 5 (Cdk5). PLoS One (2015) 0.75
HIV and Cocaine Impact Glial Metabolism: Energy Sensor AMP-activated protein kinase Role in Mitochondrial Biogenesis and Epigenetic Remodeling. Sci Rep (2016) 0.75
Effects of p35 Mutations Associated with Mental Retardation on the Cellular Function of p35-CDK5. PLoS One (2015) 0.75
Knockdown of Expression of Cdk5 or p35 (a Cdk5 Activator) Results in Podocyte Apoptosis. PLoS One (2016) 0.75
Transient enhancement of proliferation of neural progenitors and impairment of their long-term survival in p25 transgenic mice. Oncotarget (2016) 0.75
p39 Is Responsible for Increasing Cdk5 Activity during Postnatal Neuron Differentiation and Governs Neuronal Network Formation and Epileptic Responses. J Neurosci (2016) 0.75
Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell (1997) 21.42
A syndrome of multiorgan hyperplasia with features of gigantism, tumorigenesis, and female sterility in p27(Kip1)-deficient mice. Cell (1996) 8.41
Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration. Nature (1999) 5.53
A decade of CDK5. Nat Rev Mol Cell Biol (2001) 5.24
A family of human cdc2-related protein kinases. EMBO J (1992) 4.96
A structural basis for substrate specificities of protein Ser/Thr kinases: primary sequence preference of casein kinases I and II, NIMA, phosphorylase kinase, calmodulin-dependent kinase II, CDK5, and Erk1. Mol Cell Biol (1996) 4.61
Inhibition of cyclin-dependent kinases by p21. Mol Biol Cell (1995) 4.48
Neurotoxicity induces cleavage of p35 to p25 by calpain. Nature (2000) 4.31
Independent binding of the retinoblastoma protein and p107 to the transcription factor E2F. Nature (1992) 4.21
Calcium influx via the NMDA receptor induces immediate early gene transcription by a MAP kinase/ERK-dependent mechanism. J Neurosci (1996) 4.21
Phosphorylation of DARPP-32 by Cdk5 modulates dopamine signalling in neurons. Nature (1999) 3.50
NUDEL is a novel Cdk5 substrate that associates with LIS1 and cytoplasmic dynein. Neuron (2000) 3.45
Mice lacking p35, a neuronal specific activator of Cdk5, display cortical lamination defects, seizures, and adult lethality. Neuron (1997) 2.96
Cables links Cdk5 and c-Abl and facilitates Cdk5 tyrosine phosphorylation, kinase upregulation, and neurite outgrowth. Neuron (2000) 2.82
Regulation of cytoplasmic dynein behaviour and microtubule organization by mammalian Lis1. Nat Cell Biol (2000) 2.81
Involvement of the cell-cycle inhibitor Cip1/WAF1 and the E1A-associated p300 protein in terminal differentiation. Proc Natl Acad Sci U S A (1995) 2.70
Interaction between human cyclin A and adenovirus E1A-associated p107 protein. Science (1992) 2.13
The p35/Cdk5 kinase is a neuron-specific Rac effector that inhibits Pak1 activity. Nature (1998) 2.01
Comparative study of the p53-mdm2 and p53-MDMX interfaces. Oncogene (1999) 1.98
p35 and p39 are essential for cyclin-dependent kinase 5 function during neurodevelopment. J Neurosci (2001) 1.87
Hdmx stabilizes Mdm2 and p53. J Biol Chem (2000) 1.81
Inhibition of cyclin-dependent kinases, GSK-3beta and CK1 by hymenialdisine, a marine sponge constituent. Chem Biol (2000) 1.71
Serine 133-phosphorylated CREB induces transcription via a cooperative mechanism that may confer specificity to neurotrophin signals. Mol Cell Neurosci (1995) 1.68
p35, the neuronal-specific activator of cyclin-dependent kinase 5 (Cdk5) is degraded by the ubiquitin-proteasome pathway. J Biol Chem (1998) 1.63
Structure and regulation of the CDK5-p25(nck5a) complex. Mol Cell (2001) 1.57
Ubiquitin conjugation by the N-end rule pathway and mRNAs for its components increase in muscles of diabetic rats. J Clin Invest (1999) 1.45
Mutational analysis of Max: role of basic, helix-loop-helix/leucine zipper domains in DNA binding, dimerization and regulation of Myc-mediated transcriptional activation. Oncogene (1992) 1.42
Isolation and identification of the human homolog of a new p53-binding protein, Mdmx. Genomics (1997) 1.37
Amphiphysin 1 binds the cyclin-dependent kinase (cdk) 5 regulatory subunit p35 and is phosphorylated by cdk5 and cdc2. J Biol Chem (2000) 1.31
BS69, a novel adenovirus E1A-associated protein that inhibits E1A transactivation. EMBO J (1995) 1.21
Cdk5 on the brain. Cell Growth Differ (2001) 1.21
N-methyl-D-aspartate receptors are critical for mediating the effects of glutamate on intracellular calcium concentration and immediate early gene expression in cultured hippocampal neurons. Neuroscience (1995) 1.20
A mouse amidase specific for N-terminal asparagine. The gene, the enzyme, and their function in the N-end rule pathway. J Biol Chem (1996) 1.16
The brain-specific activator p35 allows Cdk5 to escape inhibition by p27Kip1 in neurons. Proc Natl Acad Sci U S A (1996) 1.15
The role of cyclin-dependent kinase 5 and a novel regulatory subunit in regulating muscle differentiation and patterning. Genes Dev (1997) 1.09
A novel disruption of cortical development in p35(-/-) mice distinct from reeler. J Comp Neurol (1998) 1.07
Mammalian Cdk5 is a functional homologue of the budding yeast Pho85 cyclin-dependent protein kinase. Proc Natl Acad Sci U S A (1999) 1.07
Abnormal morphological and functional organization of the hippocampus in a p35 mutant model of cortical dysplasia associated with spontaneous seizures. J Neurosci (2001) 1.07
Regulation of N-cadherin-mediated adhesion by the p35-Cdk5 kinase. Curr Biol (2000) 1.06
Temporal and spatial patterns of expression of p35, a regulatory subunit of cyclin-dependent kinase 5, in the nervous system of the mouse. J Neurocytol (1997) 0.93
The early effect of pelvic floor muscle exercise after transurethral prostatectomy. J Urol (1998) 0.91
Differential cellular phosphorylation of neurofilament heavy side-arms by glycogen synthase kinase-3 and cyclin-dependent kinase-5. J Neurochem (1996) 0.91
Role of AKT kinase in sphingosine-induced apoptosis in human hepatoma cells. J Cell Physiol (2001) 0.90
Varying intertrial interval reveals temporally defined memory deficits and enhancements in NTAN1-deficient mice. Learn Mem (2000) 0.90
Callosal axon guidance defects in p35(-/-) mice. J Comp Neurol (1999) 0.88
Backbone 1H, 15N, and 13C resonance assignments of inhibitor-2 -- a protein inhibitor of protein phosphatase-1. J Biomol NMR (2000) 0.88
The role of the p35/cdk5 kinase in cortical development. Results Probl Cell Differ (2000) 0.88
The cyclin-dependent kinase family. Cold Spring Harb Symp Quant Biol (1991) 0.87
Synaptic localization of p39, a neuronal activator of cdk5. Neuroreport (2000) 0.87
Cyclin E-p27 opposition and regulation of the G1 phase of the cell cycle in the murine neocortical PVE: a quantitative analysis of mRNA in situ hybridization. Cereb Cortex (1999) 0.87
Characterization of carbapenem-nonsusceptible Klebsiella pneumoniae bloodstream isolates at a Taiwanese hospital: clinical impacts of lowered breakpoints for carbapenems. Eur J Clin Microbiol Infect Dis (2012) 0.85
Bloodstream infections caused by IMP-8-producing Enterobacteriaceae isolates: the need for clinical laboratory detection of metallo-β-lactamases? Eur J Clin Microbiol Infect Dis (2012) 0.85
Murine myeloid leukemic cells with disrupted myb loci show splicing anomalies that account for heterogeneous sizes in myb proteins. Oncogene (1996) 0.83
Cell cycle control. Adv Exp Med Biol (2000) 0.82
Hyperthermia enhances mapatumumab-induced apoptotic death through ubiquitin-mediated degradation of cellular FLIP(long) in human colon cancer cells. Cell Death Dis (2013) 0.82
Neoplasms of the central nervous system of lipoid origin. Pol J Pathol (2000) 0.79
Loss of Ubr1 promotes aneuploidy and accelerates B-cell lymphomagenesis in TLX1/HOX11-transgenic mice. Oncogene (2006) 0.78
Activity and regulation of p35/Cdk5 kinase complex. Methods Enzymol (2000) 0.78
Neuroscience. A kinase to dampen the effects of cocaine? Science (2001) 0.77
CML patients in blast crisis have breakpoints localized to a specific region of the BCR. Blood (1987) 0.77
Vasoactive intestinal polypeptide provokes acetylcholine release from the myenteric plexus. Am J Physiol (1986) 0.77
[Participation of free radicals in the mechanism of brain tissue damage]. Neurol Neurochir Pol (1994) 0.77
Protective effect of excitatory amino acids on cold-restraint stress-induced gastric ulcers in mice: role of cyclic nucleotides. Dig Dis Sci (2001) 0.76
Backbone 1H, 15N, and 13C resonance assignments of ARPP-19. J Biomol NMR (2001) 0.76
Cdk5 at the junction. Nat Neurosci (2001) 0.75
[Rare case of corpus callosum lipoma in a 12-year-old boy]. Pol Przegl Radiol Med Nukl (1975) 0.75
Inactivation of Formosan snake venoms in vitro by the crude extract of Aristolochia radix. Taiwan Yi Xue Hui Za Zhi (1975) 0.75
[Use of the Leukocyte Migration Inhibition test (LMI) in the diagnosis of chromium]. Dermatol Monatsschr (1977) 0.75
[Clinico-radiological analysis of surgically treated sciatica cases]. Pol Tyg Lek (1991) 0.75
[Results of the glycosuria-prednisone test (GPT) in psoriatics]. Przegl Dermatol (1974) 0.75
[Use of the leukocyte migration inhibition test (MIF) in the detection of hypersensitivity to chromium compounds. I. Combination of human albumin with chromium as an antigen in MIF]. Przegl Dermatol (1975) 0.75
Pharmacological characterization of alpha 2-adrenoceptors in isolated jejunum of rabbits. Chin J Physiol (1992) 0.75
Influence of whole-body mechanical vibration on altitude convulsion threshold. Chin J Physiol (1978) 0.75
[Case of central nervous system damage with marked kynurenuria]. Neurol Neurochir Pol (1975) 0.75
[A case of porphyria cutanea tarda sclerodermiformis]. Przegl Dermatol (1971) 0.75
[Detection of hypersensitivity to chromium, cobalt and nickel by means of the leukocyte migration inhibition test]. Przegl Dermatol (1979) 0.75
[A new micromethod for the qualitative determination of blood urea]. Clin Chim Acta (1966) 0.75
[The role of a Medical Academy in graduate medical training]. Rocz Akad Med Im Juliana Marchlewskiego Bialymst Suppl (1974) 0.75
[Determination of the level of prolapsed intervertebral disk in ischalgia by means of an electric thermometer]. Pol Tyg Lek (1973) 0.75
[Xylose test in patients with attacks of headaches (migraine, Horton's headache)]. Neurol Neurochir Pol (1979) 0.75
[Leg skin temperature before and following removal of the lumbar disk]. Chir Narzadow Ruchu Ortop Pol (1973) 0.75
Grundig ZK-140 tape recorder used for analogue magnetic recording of electrocardiograms and encephalograms during general anaesthesia. Anaesth Resusc Intensive Ther (1974) 0.75
[Serum zinc level in patients with myocardial infarct and its clinical significance]. Pol Tyg Lek (1977) 0.75
Immunobiologic, cytogenetic and drug response features of a newly established cell line (SCRC-1) from renal small cell carcinoma. J Urol (2000) 0.75
[Difference in facial skin temperature following peripheral or central injury of the facial nerve as correlated with electromyographic studies]. Pol Tyg Lek (1974) 0.75
[Trace elements (Cu, Fe, Mg) in the serum of patients with connective tissue diseases]. Przegl Dermatol (1972) 0.75
[Effect of leukeran on iron, copper, transferrin and ceruloplasmin levels in blood serum in systemic scleroderma after long-term treatment]. Reumatologia (1979) 0.75
[Giant intradural disk herniation]. Chir Narzadow Ruchu Ortop Pol (2001) 0.75
Whole-body mechanical vibration and incidence of decompression-induced pulmonary hemorrhage in mice. Taiwan Yi Xue Hui Za Zhi (1982) 0.75
[Serum iron, copper, transferrin and ceruloplasmin levels in patients with diffuse scleroderma treated with 6-mercaptopurine]. Przegl Dermatol (1975) 0.75
[Spinal lipoma in the Th 2 -Th 3 region]. Neurol Neurochir Pol (1973) 0.75
The effect of methoxyflurane on certain renal function parameters. Anaesth Resusc Intensive Ther (1976) 0.75